ArticleTherapeutic advances in medical oncology2024

Pharmacokinetics, safety, and efficacy of an alternative dosing regimen of sasanlimab in participants with advanced NSCLC and other malignancies.

Konstantin Penkov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.